Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA. Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA. Broad Institute of Harvard and Massachusetts Institute of Techonology (MIT), Cambridge, MA 02142, USA. Howard Hughes Medical Institute Chevy Chase, MD 20815, USA.
Broad Institute of Harvard and Massachusetts Institute of Techonology (MIT), Cambridge, MA 02142, USA.
Science. 2014 Jun 20;344(6190):1396-401. doi: 10.1126/science.1254257. Epub 2014 Jun 12.
Human cancers are complex ecosystems composed of cells with distinct phenotypes, genotypes, and epigenetic states, but current models do not adequately reflect tumor composition in patients. We used single-cell RNA sequencing (RNA-seq) to profile 430 cells from five primary glioblastomas, which we found to be inherently variable in their expression of diverse transcriptional programs related to oncogenic signaling, proliferation, complement/immune response, and hypoxia. We also observed a continuum of stemness-related expression states that enabled us to identify putative regulators of stemness in vivo. Finally, we show that established glioblastoma subtype classifiers are variably expressed across individual cells within a tumor and demonstrate the potential prognostic implications of such intratumoral heterogeneity. Thus, we reveal previously unappreciated heterogeneity in diverse regulatory programs central to glioblastoma biology, prognosis, and therapy.
人类癌症是由具有不同表型、基因型和表观遗传状态的细胞组成的复杂生态系统,但目前的模型不能充分反映患者肿瘤的组成。我们使用单细胞 RNA 测序(RNA-seq)对来自五个原发性脑胶质瘤的 430 个细胞进行了分析,发现它们在与致癌信号、增殖、补体/免疫反应和缺氧相关的多种转录程序的表达上存在固有差异。我们还观察到一个与干性相关的表达状态连续体,使我们能够鉴定体内干性的潜在调节因子。最后,我们表明,已建立的脑胶质瘤亚型分类器在肿瘤内的单个细胞中表达情况各不相同,并证明了这种肿瘤内异质性的潜在预后意义。因此,我们揭示了先前未被重视的与胶质母细胞瘤生物学、预后和治疗相关的各种调节程序中的异质性。